REATA PHARMACEUTICALS INC Quarterly Depreciation in USD from Q1 2017 to Q2 2023

Taxonomy & unit: us-gaap: USD
Description: The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary: Reata Pharmaceuticals Inc quarterly/annual Depreciation history and growth rate from Q1 2017 to Q2 2023.
Reata Pharmaceuticals Inc Depreciation for the quarter ending June 30, 2023 was $293K, a 7.33% increase year-over-year.
Reata Pharmaceuticals Inc Depreciation for the twelve months ending June 30, 2023 was $1.13M, a 7.6% decline year-over-year.
Reata Pharmaceuticals Inc annual Depreciation for 2022 was $1.13M, a 6.07% decline from 2021.
Reata Pharmaceuticals Inc annual Depreciation for 2021 was $1.2M, a 5.9% increase from 2020.
Reata Pharmaceuticals Inc annual Depreciation for 2020 was $1.14M, a 21.9% increase from 2019.

Depreciation, Trailing 12 Months (USD)

Depreciation, Quarterly (USD)

Depreciation, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2023	$1.13M	$293K	+$20K	+7.33%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$1.11M	$288K	-$20K	-6.49%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-10
Q4 2022	$1.13M	$277K	-$45K	-14%	Oct 1, 2022	Dec 31, 2022	10-K	2023-02-24
Q3 2022	$1.18M	$272K	-$48K	-15%	Jul 1, 2022	Sep 30, 2022	10-Q	2022-11-08
Q2 2022	$1.22M	$273K	-$14K	-4.88%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-08
Q1 2022	$1.24M	$308K	+$34K	+12.4%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-10
Q4 2021	$1.2M	$322K	+$37K	+13%	Oct 1, 2021	Dec 31, 2021	10-K	2023-02-24
Q3 2021	$1.17M	$320K	+$31K	+10.7%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-08
Q2 2021	$1.14M	$287K	+$3K	+1.06%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-08
Q1 2021	$1.13M	$274K	-$4K	-1.44%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-10
Q4 2020	$1.14M	$285K	+$13K	+4.78%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-24
Q3 2020	$1.12M	$289K	+$31K	+12%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-08
Q2 2020	$1.09M	$284K	+$52K	+22.4%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-09
Q1 2020	$1.04M	$278K	+$108K	+63.5%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06
Q4 2019	$932K	$272K	+$152K	+127%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-28
Q3 2019	$780K	$258K	+$153K	+146%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-09
Q2 2019	$627K	$232K	+$127K	+121%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-10
Q1 2019	$500K	$170K	+$69K	+68.3%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-11
Q4 2018	$431K	$120K			Oct 1, 2018	Dec 31, 2018	10-K	2021-03-01
Q3 2018		$105K			Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12
Q2 2018		$105K			Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-08
Q1 2018		$101K	-$29K	-22.3%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-09
Q1 2017		$130K			Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-08

* An asterisk sign (*) next to the value indicates that the value is likely invalid.